TD Cowen analyst Gary Taylor lowered the firm’s price target on Molina Healthcare (MOH) to $342 from $378 and keeps a Buy rating on the shares.
Healthcare insurance company Molina Healthcare (NYSE:MOH) announced in Q4 CY2024, with sales up 16% year on year to $10.5 ...
Molina Healthcare, Inc. MOH reported fourth-quarter 2024 adjusted earnings per share (EPS) of $5.05, which missed the Zacks ...
Molina’s Medicaid medical expenses surged 6.5% in 2024 according to the company's fourth-quarter and full-year earnings report, which it released Wednesday. Higher-acuity care, long-term care ...
Molina does not pay a dividend. The South African-based specialty chemicals and energy company this week took out its early June support level and kept going lower. You can see on the chart that ...
Molina reports higher-than-feared Medicaid costs; shares tumble February 5, 2025 U.S. stocks ended lower on Thursday, with UnitedHealth down sharply and technology shares easing as investors ...
Healthcare plan provider Molina Healthcare ... However, rising costs and lower investment income make an earnings beat uncertain. The Zacks Consensus Estimate for investment income indicates ...
Price to Sales (P/S) Ratio: The P/S ratio of 0.43 is lower than the industry average, implying a discounted valuation for Molina Healthcare's stock in relation to sales performance. EV/EBITDA ...